J. Zhang

Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial.

José Miguel Contreras, G. Lip, J. De Sutter, 2021, The lancet. Diabetes & endocrinology.

Phase‐Separation‐Induced Micropatterned Polymer Surfaces and Their Applications

B. Han, Y. Wang, J. Zhang, 2005 .